monteplase
Recombinant proteinexperimental
Monteplase is an antithrombic proposed for use in acute myocardial infarction. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started May 1, 2007 (NCT00442234)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Tissue-type plasminogen activatorEXOGENOUS PROTEIN
Tissue-type plasminogen activator exogenous protein
- Tissue-type plasminogen activatorSupplementation
PLAT supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMonteplase ↗
- ChEMBLCHEMBL2108426 ↗
Also known as
- monteplase
- monteplase
- monteplase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00442234 | Phase 4 | May 1, 2007 | Eisai |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 1 | 1 | 1 | 2007 |
1 organizations
Page 1 / 1